🇺🇸 FDA
Patent

US 8778398

Immediate release formulations and dosage forms of gamma-hydroxybutyrate

granted A61KA61K31/19A61K31/191

Quick answer

US patent 8778398 (Immediate release formulations and dosage forms of gamma-hydroxybutyrate) held by Jazz Pharmaceuticals, Inc. expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals, Inc.
Grant date
Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/19, A61K31/191, A61K9/1652, A61K9/2009